BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1254 related articles for article (PubMed ID: 19651580)

  • 1. Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder.
    Brinkman WB; Sherman SN; Zmitrovich AR; Visscher MO; Crosby LE; Phelan KJ; Donovan EF
    Pediatrics; 2009 Aug; 124(2):580-9. PubMed ID: 19651580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How parents make decisions to use medication to treat their child's ADHD: a grounded theory study.
    Cormier E
    J Am Psychiatr Nurses Assoc; 2012; 18(6):345-56. PubMed ID: 23149857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P; Hsu HY; Chiou SS; Chao MC
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of medication adherence in children and adults with ADHD.
    Adler LD; Nierenberg AA
    Postgrad Med; 2010 Jan; 122(1):184-91. PubMed ID: 20107302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caught in a balancing act: parents' dilemmas regarding their ADHD child's treatment with stimulant medication.
    Hansen DL; Hansen EH
    Qual Health Res; 2006 Nov; 16(9):1267-85. PubMed ID: 17038757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parental attitudes and involvement in psychopharmacological treatment for ADHD: a conceptual model.
    dosReis S; Myers MA
    Int Rev Psychiatry; 2008 Apr; 20(2):135-41. PubMed ID: 18386203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment choices and experiences in attention deficit and hyperactivity disorder: relations to parents' beliefs and attributions.
    Johnston C; Seipp C; Hommersen P; Hoza B; Fine S
    Child Care Health Dev; 2005 Nov; 31(6):669-77. PubMed ID: 16207224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive changes related to medication treatment of ADHD: listening to parents of children in clinical trials of a novel nonstimulant medication.
    Saylor KE; Buermeyer CM; Spencer TJ; Barkley RA
    J Clin Psychiatry; 2002; 63 Suppl 12():23-8. PubMed ID: 12562058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability of behavioral and pharmacological treatments for attention-deficit/hyperactivity disorder: relations to child and parent characteristics.
    Johnston C; Hommersen P; Seipp C
    Behav Ther; 2008 Mar; 39(1):22-32. PubMed ID: 18328867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of attention deficit hyperactivity disorder: a parental perspective.
    Concannon PE; Tang YP
    J Paediatr Child Health; 2005 Dec; 41(12):625-30. PubMed ID: 16398864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United kingdom.
    Secnik K; Matza LS; Cottrell S; Edgell E; Tilden D; Mannix S
    Med Decis Making; 2005; 25(1):56-70. PubMed ID: 15673582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming the barriers to effective treatment for attention-deficit/hyperactivity disorder: a neuro-educational approach.
    Monastra VJ
    Int J Psychophysiol; 2005 Oct; 58(1):71-80. PubMed ID: 15927296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New options in the pharmacological management of attention-deficit/hyperactivity disorder.
    Olfson M
    Am J Manag Care; 2004 Jul; 10(4 Suppl):S117-24. PubMed ID: 15352538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of drug therapy in children with attention deficit hyperactivity disorder (ADHD): maternal views and experiences.
    Jackson D; Peters K
    J Clin Nurs; 2008 Oct; 17(20):2725-32. PubMed ID: 18808641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethnic differences in parental beliefs of attention-deficit/hyperactivity disorder and treatment.
    Pham AV; Carlson JS; Kosciulek JF
    J Atten Disord; 2010 May; 13(6):584-91. PubMed ID: 19414623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes toward attention-deficit hyperactivity disorder (ADHD) treatment: parents' and children's perspectives.
    Berger I; Dor T; Nevo Y; Goldzweig G
    J Child Neurol; 2008 Sep; 23(9):1036-42. PubMed ID: 18487521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Educating and counseling of parents of children with attention-deficit hyperactivity disorder.
    Ghanizadeh A
    Patient Educ Couns; 2007 Sep; 68(1):23-8. PubMed ID: 17467224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of treatment refractory attention-deficit/hyperactivity disorder in children and adolescents.
    Wagner KD
    Psychopharmacol Bull; 2002; 36(1):130-42. PubMed ID: 12397852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.